C
Amneal Pharmaceuticals, Inc. AMRX
$10.48 $0.121.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 3.24% 5.50% 18.40% 13.29% 17.15%
Total Other Revenue -- -- -- -- --
Total Revenue 3.24% 5.50% 18.40% 13.29% 17.15%
Cost of Revenue -2.78% 4.54% 19.69% 11.97% 19.23%
Gross Profit 14.19% 7.19% 16.17% 15.52% 13.55%
SG&A Expenses 6.70% 5.06% 18.06% 5.03% 10.32%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -5,222.00% -- -- --
Total Operating Expenses 1.17% 3.55% 19.20% 13.23% 15.70%
Operating Income 16.20% 18.61% 12.21% 13.75% 27.13%
Income Before Tax 153.42% 149.64% 81.65% -32.82% -31.20%
Income Tax Expenses 345.02% 109.03% -45.13% 276.59% 15,830.43%
Earnings from Continuing Operations 112.13% 130.14% 77.78% -53.03% -43.45%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -22.24% -24.67% -94.89% 22.40% 39.25%
Net Income 273.99% 113.31% 68.49% -101.61% -49.70%
EBIT 16.20% 18.61% 12.21% 13.75% 27.13%
EBITDA 13.27% 14.56% 13.98% 9.20% 14.32%
EPS Basic 268.56% 113.15% 75.22% -100.80% -74.97%
Normalized Basic EPS 10,266.67% 310.11% -661.54% -4,600.00% 104.88%
EPS Diluted 260.82% 113.07% 75.22% -100.83% -74.97%
Normalized Diluted EPS 10,000.00% 294.38% -661.54% -4,600.00% 104.92%
Average Basic Shares Outstanding 1.50% 1.23% 27.14% 100.78% 101.07%
Average Diluted Shares Outstanding 1.07% 5.43% 27.14% 93.90% 105.93%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --